BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 9295349)

  • 41. Leukemia inhibitory factor and its receptor promote adipocyte differentiation via the mitogen-activated protein kinase cascade.
    Aubert J; Dessolin S; Belmonte N; Li M; McKenzie FR; Staccini L; Villageois P; Barhanin B; Vernallis A; Smith AG; Ailhaud G; Dani C
    J Biol Chem; 1999 Aug; 274(35):24965-72. PubMed ID: 10455174
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Differential response of neuronal cells to a fusion protein of ciliary neurotrophic factor/soluble CNTF-receptor and leukemia inhibitory factor.
    März P; Ozbek S; Fischer M; Voltz N; Otten U; Rose-John S
    Eur J Biochem; 2002 Jun; 269(12):3023-31. PubMed ID: 12071967
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Involving of the cytoplasmic region of leukemia inhibitory factor receptor alpha subunit, IL-6 related signal transducer-gp130 or fas death domain for MAPK p42/44 activation in HL-60 cell with LIF or anti-Fas IgG.
    Liu H; Dan J; Tang S; Wu S
    Mol Cell Biochem; 2001 Jan; 217(1-2):113-20. PubMed ID: 11269654
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Structural and functional studies on the leukemia inhibitory factor receptor (LIF-R): gene and soluble form of LIF-R, and cytoplasmic domain of LIF-R required for differentiation and growth arrest of myeloid leukemic cells.
    Tomida M
    Leuk Lymphoma; 2000 May; 37(5-6):517-25. PubMed ID: 11042511
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Molecular cloning and functional expression of mouse cDNAs encoding the membrane receptor and the soluble receptor for D-factor/LIF.
    Tomida M
    Ann N Y Acad Sci; 1995 Jul; 762():480-1. PubMed ID: 7668564
    [No Abstract]   [Full Text] [Related]  

  • 46. Epitope-function relationships of human leukemia inhibitory factor receptors using a novel set of anti-gp190 mAB.
    Blanchard F; Pitard V; Taupin JL; Raher S; Hallet MM; Moreau JF; Godard A; Jacques Y
    Int Immunol; 1997 Dec; 9(12):1775-84. PubMed ID: 9466305
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The crystal structure and biological function of leukemia inhibitory factor: implications for receptor binding.
    Robinson RC; Grey LM; Staunton D; Vankelecom H; Vernallis AB; Moreau JF; Stuart DI; Heath JK; Jones EY
    Cell; 1994 Jul; 77(7):1101-16. PubMed ID: 8020098
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A family of leukemia inhibitory factor-binding peptides that can act as antagonists when conjugated to poly(ethylene glycol).
    Fairlie WD; Uboldi AD; Hemmings GJ; Smith BJ; Martin HM; Morgan PO; Baca M
    Biochemistry; 2003 Nov; 42(45):13193-201. PubMed ID: 14609330
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Leukemia inhibitory factor (LIF) and oncastsin M (OSM) high affinity binding require additional receptor subunits besides GP130 and GP190.
    Heymann D; Godard A; Raher S; Bentouimou N; Blanchard F; Cherel M; Hallet MM; Jacques Y
    Cytokine; 1996 Mar; 8(3):197-205. PubMed ID: 8833034
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification and characterization of two distinct truncated forms of gp130 and a soluble form of leukemia inhibitory factor receptor alpha-chain in normal human urine and plasma.
    Zhang JG; Zhang Y; Owczarek CM; Ward LD; Moritz RL; Simpson RJ; Yasukawa K; Nicola NA
    J Biol Chem; 1998 Apr; 273(17):10798-805. PubMed ID: 9553147
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Binding interactions of leukemia inhibitory factor and ciliary neurotrophic factor with the different subunits of their high affinity receptors.
    Robledo O; Auguste P; Coupey L; Praloran V; Chevalier S; Pouplard A; Gascan H
    J Neurochem; 1996 Apr; 66(4):1391-9. PubMed ID: 8627290
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differential inhibition of IL-6-type cytokine-induced STAT activation by PMA.
    Terstegen L; Maassen BG; Radtke S; Behrmann I; Schaper F; Heinrich PC; Graeve L; Gatsios P
    FEBS Lett; 2000 Jul; 478(1-2):100-4. PubMed ID: 10922477
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Expression of leukemia inhibitory factor and its receptor in breast cancer: a potential autocrine and paracrine growth regulatory mechanism.
    Dhingra K; Sahin A; Emami K; Hortobagyi GN; Estrov Z
    Breast Cancer Res Treat; 1998 Mar; 48(2):165-74. PubMed ID: 9596488
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Leukemia inhibitory factor receptor signaling negatively modulates nerve growth factor-induced neurite outgrowth in PC12 cells and sympathetic neurons.
    Ng YP; He W; Ip NY
    J Biol Chem; 2003 Oct; 278(40):38731-9. PubMed ID: 12871977
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dual control of LIF expression and LIF receptor function regulate Stat3 activation at the onset of uterine receptivity and embryo implantation.
    Cheng JG; Chen JR; Hernandez L; Alvord WG; Stewart CL
    Proc Natl Acad Sci U S A; 2001 Jul; 98(15):8680-5. PubMed ID: 11438698
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Testicular leukemia inhibitory factor (LIF) and LIF receptor mediate phosphorylation of signal transducers and activators of transcription (STAT)-3 and STAT-1 and induce c-fos transcription and activator protein-1 activation in rat Sertoli but not germ cells.
    Jenab S; Morris PL
    Endocrinology; 1998 Apr; 139(4):1883-90. PubMed ID: 9528974
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Regulation of interleukin 6 expression by cardiotrophin 1.
    Robledo O; Chevalier S; Froger J; Barthelaix-Pouplard A; Pennica D; Gascan H
    Cytokine; 1997 Sep; 9(9):666-71. PubMed ID: 9325015
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A dual, non-redundant, role for LIF as a regulator of development and STAT3-mediated cell death in mammary gland.
    Kritikou EA; Sharkey A; Abell K; Came PJ; Anderson E; Clarkson RW; Watson CJ
    Development; 2003 Aug; 130(15):3459-68. PubMed ID: 12810593
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification of ciliary neurotrophic factor (CNTF) residues essential for leukemia inhibitory factor receptor binding and generation of CNTF receptor antagonists.
    Di Marco A; Gloaguen I; Graziani R; Paonessa G; Saggio I; Hudson KR; Laufer R
    Proc Natl Acad Sci U S A; 1996 Aug; 93(17):9247-52. PubMed ID: 8799186
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Expression of CNTF/LIF-receptor components and activation of STAT3 signaling in axotomized facial motoneurons: evidence for a sequential postlesional function of the cytokines.
    Haas CA; Hofmann HD; Kirsch M
    J Neurobiol; 1999 Dec; 41(4):559-71. PubMed ID: 10590179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.